1 completed, 1 terminated, 1 unknown, 1 withdrawn. 1 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Withdrawn 1 |
Follow Toremifene citrate: new trials by email Literature Review of Toremifene citrate trials Research Report on Toremifene citrate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Breast Cancer Treatment Based on Organ-like Culture Trastuzumab, Doxorubicin Hydrochloride, Epirubicin hydrochloride - Breast Cancer Organoids | Unknown | Xijing Hospital | 300 | 2019-01-02 | 2019-04-24 | |
| Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer Anastrozole, Exemestane, Laboratory Biomarker Analysis - HER2/Neu Negative, Invasive Breast Carcinoma | Phase 4 | Withdrawn | Fred Hutchinson Cancer Center | 2018-09-01 | 2018-12-27 | |
| Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast Cancer Toremifene citrate, Anastrozole - Breast Neoplasms | Phase 2 | Terminated | Japan Breast Cancer Research Network | 240 | 2007-05-01 | 2012-03-30 |
| Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy Toremifene Citrate - Prostate Cancer, Osteoporosis | Phase 3 | Completed | GTx | 1200 | 2003-10-01 | 2013-11-15 |
Breast Neoplasms (2) · Bone Diseases, Metabolic (1) · Breast Carcinoma In Situ (1) · Fractures, Bone (1) · Osteoporosis (1) · Prostatic Neoplasms (1)
Fred Hutchinson Cancer Center (1) · GTx (1) · Japan Breast Cancer Research Network (1) · Xijing Hospital (1)
United States (2) · China (1) · Japan (1) · Mexico (1)
Mitchell Steiner, M.D. (1) · Satoru Iwase, MD (1) · Vijayakrishna Gadi (1)
P30CA015704 (1)